Emma Assi
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
Papers in
-
- Diabetes Management and Research 5
- Diabetes Treatment and Management 3
- Genetics 12
- Diabetes and associated disorders 9
- Digestive system and related health 2
- Co-authors
- Emilio Clementi (9 shared papers)Cristiana Perrotta (9 shared papers)Clara De Palma (8 shared papers)Davide Cervia (8 shared papers)Paolo Fiorina (12 shared papers)Moufida Ben Nasr (9 shared papers)Cristian Loretelli (8 shared papers)Gianvincenzo Zuccotti (6 shared papers)
- Journals
- Pharmacological Research (6 papers)Diabetes (2 papers)Frontiers in Immunology (2 papers)Oncotarget (2 papers)Acta Diabetologica (2 papers)
- Partner nations
- ItalyUnited StatesEgypt
In The Last Decade
Emma Assi
37 papers receiving 1.7k citations
Emma Assi's Hit Papers
Peers
Comparison fields: 5 of 102
- Endocrinology, Diabetes and Metabolism 380
- Infectious Diseases 238
- Neurology 146
- Immunology 178
- Physiology 40
Countries citing papers authored by Emma Assi
This map shows the geographic impact of Emma Assi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Assi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Assi more than expected).
Fields of papers citing papers by Emma Assi
This network shows the impact of papers produced by Emma Assi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Assi. The network helps show where Emma Assi may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma Assi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection Hit paper breakdown → | 2021 | 308 |
| 2 | The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists Hit paper breakdown → | 2022 | 293 |
| 3 | 2013 | 103 | |
| 4 | 2024 | 71 | |
| 5 | 2014 | 65 | |
| 6 | 2021 | 64 | |
| 7 | 2010 | 60 | |
| 8 | 2021 | 49 | |
| 9 | 2013 | 44 | |
| 10 | 2021 | 44 | |
| 11 | 2013 | 42 | |
| 12 | 2013 | 42 | |
| 13 | 2022 | 40 | |
| 14 | 2020 | 39 | |
| 15 | 2022 | 37 | |
| 16 | 2015 | 37 | |
| 17 | 2016 | 36 | |
| 18 | 2020 | 35 | |
| 19 | 2023 | 34 | |
| 20 | 2020 | 31 |
About Emma Assi
Emma Assi is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Surgery, Immunology and Physiology, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (10 papers), Diabetes and associated disorders (9 papers), Sphingolipid Metabolism and Signaling (6 papers), Diabetes Management and Research (5 papers), COVID-19 Clinical Research Studies (4 papers), Adenosine and Purinergic Signaling (3 papers), Diabetes Treatment and Management (3 papers) and Digestive system and related health (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (380 citations), Infectious Diseases (238 citations), Neurology (146 citations), Immunology (178 citations) and Physiology (40 citations). Emma Assi has collaborated with scholars based in Italy, United States and Egypt. Frequent co-authors include Emilio Clementi, Cristiana Perrotta, Clara De Palma, Davide Cervia, Paolo Fiorina, Moufida Ben Nasr, Cristian Loretelli, Gianvincenzo Zuccotti, Francesca D’Addio and Ida Pastore. Their work appears in journals such as Pharmacological Research, Diabetes, Frontiers in Immunology, Oncotarget and Acta Diabetologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.